Osteoarthritis Pathophysiology
Osteoarthritis initiates with chondrocyte dysfunction and cartilage matrix degradation. Pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) activate matrix metalloproteinases (MMPs) that degrade collagen II and proteoglycans. Chondrocyte apoptosis reduces matrix-producing capacity. Synovial macrophages produce inflammatory mediators, perpetuating cartilage loss.
Spirulina Mechanisms
Sulfated Polysaccharide-Mediated Chondrocyte Protection
Spirulina’s sulfated polysaccharides (0.5–2% dry weight) activate TGF-β signaling, promoting collagen II and proteoglycan synthesis (+20–30%). Suppression of NF-κB activation reduces TNF-α and IL-1β-induced MMP expression by 30–40%.
Phycocyanin Anti-Apoptosis
Spirulina’s phycocyanin activates PI3K/Akt survival pathways in chondrocytes, suppressing caspase-3 activation by 25–35%, preserving chondrocyte viability and matrix-producing capacity.
Synovial Inflammation Suppression
Spirulina’s polyphenols inhibit synovial macrophage TNF-α, IL-6, IL-1β production (30–40% reduction), suppressing MMP-9 secretion and synovial PGE2 levels by 25–35%.
Outcomes
Supplementation (5–10g daily for 8–12 weeks) shows: 20–30% joint pain reduction, 15–25% swelling improvement, 10–15% mobility increase, cartilage volume preservation vs control decline, synovial TNF-α/IL-6 reduction of 25–40%.
Summary
Spirulina protects joint health through sulfated polysaccharide ECM synthesis promotion, phycocyanin-mediated chondrocyte apoptosis suppression, and polyphenol synovial inflammation reduction, slowing OA progression and improving pain/function.